Neoantigen targetability in progressive advanced melanoma. van den Bulk J, Verdegaal EME, van der Ploeg M, Visser M, et al. Clin Cancer Res 2023 Aug 4:CCR-23-1106. doi: 10.1158/1078-0432.CCR-23-1106.

Read + Share

Amedeo Smart

Independent Medical Education

van den Bulk J, Verdegaal EME, van der Ploeg M, Visser M, et al. Neoantigen targetability in progressive advanced melanoma. Clin Cancer Res 2023 Aug 4:CCR-23-1106. doi: 10.1158/1078-0432.CCR-23-1106.
PMID: 37540567